Quantcast
Last updated on April 18, 2014 at 11:57 EDT

Latest stroke Stories

2014-02-14 11:11:55

Abstract TMP24 (Room Hall G) Hispanic stroke patients admitted to hospitals in the border states of California, Arizona, New Mexico and Texas were less likely than non-Hispanics in the same border states to receive clot-busting drugs and more likely to die, according to research presented at the American Stroke Association's International Stroke Conference 2014. Researchers analyzed stroke care for Hispanic and non-Hispanic patients according to demographics and clinical characteristics...

2014-02-14 11:10:42

Abstract TMP66 (Room Hall G) Suffering an injury to the head or neck increases ischemic stroke risk three-fold among trauma patients younger than 50, according to research presented at the American Stroke Association's International Stroke Conference 2014. "These findings are important because strokes after trauma might be preventable," said Christine Fox, M.D., M.A.S., lead author and assistant professor of neurology at the University of California San Francisco. Researchers studied...

2014-02-14 08:26:18

MOUNTAIN VIEW, Calif., Feb. 14, 2014 /PRNewswire/ -- SanBio today announced the presentation of safety and efficacy data from its on-going Phase 1/2a clinical trial of SB623 cell therapy in patients with chronic stroke disability. The presentation was made by Dr. Gary Steinberg, M.D., Ph.D., Bernard and Ronni Lacroute-William Randolph Hearst Professor of Neurosurgery and the Neurosciences, Chairman, Department of Neurosurgery, Stanford University School of Medicine, at a scientific...

2014-02-14 08:26:09

RARITAN, N.J., Feb. 14, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) announced today the U.S. Food and Drug Administration (FDA) issued complete response letters (CRLs) regarding supplemental New Drug Applications (sNDAs) for the use of XARELTO(®) (rivaroxaban), an oral anticoagulant, to reduce the risk of secondary cardiovascular events - defined as heart attack, stroke or death - in patients with acute coronary syndrome (ACS) and to reduce the risk of stent...

2014-02-13 16:27:43

Enabling Prevention of Heart Disease By Early Detection DOHA, Qatar and IRVINE, Calif., Feb. 13, 2014 /PRNewswire/ -- HealthMed Holdings, a company dedicated to the prevention of cardiovascular disease through innovative laboratory tests in conjunction with preventive strategies, announced today that it has completed validation on a novel blood test that aims to identify individuals who are at risk of a heart attack that might be missed by conventional tests. These individuals have...

2014-02-13 08:30:55

SAN FRANCISCO, Feb. 13, 2014 /PRNewswire/ -- iRhythm Technologies, Inc., a healthcare information services company, today announced that new study data support the use of its ZIO Service to help identify underlying cardiac arrhythmias in patients who have had a stroke or transient ischemic attack (TIA). The ZIO Service enables long-term continuous monitoring - using a noninvasive, small, wearable patch - to detect sporadic heart rhythm disturbances, including atrial fibrillation (AF),...

2014-02-13 08:30:53

AUSTIN, Texas, Feb. 13, 2014 /PRNewswire/ -- Hanger, Inc. (NYSE: HGR) today announced the publication of the findings of the Company's INSTRIDE WalkAide trial in the peer-reviewed journal Neurorehabilitation and Neural Repair. The Company has submitted these findings to the Centers of Medicare and Medicaid Services (CMS) as part of a request for expanded coverage for the WalkAide. The clinical trial proved that the WalkAide is equivalent to the current standard of care, the Ankle...

2014-02-12 23:31:05

Roger C. Denton, Plaintiffs' Co-Lead Counsel in the Pradaxa® MDL, provides update for the Pradaxa Multidistrict Litigation (MDL 2385), particularly that numerous internal company documents have been unsealed and made publicly available. St. Louis, MO (PRWEB) February 12, 2014 On February 7, 2014, The New York Times reported that numerous documents have been made public in the Pradaxa® Multidistrict Litigation entitled In re: Pradaxa® (Dabigatran Etexilate) Products...

2014-02-12 23:27:48

National Network of Attorneys now reviewing consumer inquiries in connection with FDA review over concerns testosterone treatments may have cause strokes and heart attacks. San Diego, CA (PRWEB) February 12, 2014 http://www.resource4thepeople.com/defectivedrugs/testosteronetreatments-lawsuits.html Resource4thePeople announced today that its national team of lawyers is now reviewing claims of heart attacks and strokes from testosterone treatment as detailed in a recent U.S. Food and Drug...

2014-02-12 23:26:47

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today. Chicago, IL (PRWEB) February 12, 2014 The prescription drug safety center DrugNews.net is announcing new information on the site for patients taking the blood thinner Pradaxa. A new report over documents unsealed by a federal judge shows the maker of the drug worried an internal study might hurt sales if released*. DrugNews was...


Latest stroke Reference Libraries

Stroke
2012-05-02 19:35:56

Stroke is a peer-reviewed medical journal published monthly by Lippincott Williams & Wilkins on behalf of the American Heart Association. As of May 2012, the current editor-in-chief is Marc Fisher (University of Massachusetts Medical School). Stroke covers research on cerebral circulation and related diseases, including clinical research on assessment of risk for stroke, diagnosis, prevention, and treatment, as well as rehabilitation. The audience base for Stroke includes neurologists,...

More Articles (1 articles) »